Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

George Bakris

Concepts (902)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hypertension
409
2019
1141
67.130
Why?
Antihypertensive Agents
263
2019
532
44.410
Why?
Blood Pressure
249
2020
1127
33.030
Why?
Diabetic Nephropathies
126
2020
211
27.330
Why?
Diabetes Mellitus, Type 2
150
2020
1144
23.260
Why?
Kidney Diseases
96
2019
415
21.310
Why?
Angiotensin-Converting Enzyme Inhibitors
138
2018
238
19.510
Why?
Renal Insufficiency, Chronic
67
2020
226
18.550
Why?
Cardiovascular Diseases
130
2020
717
17.850
Why?
Albuminuria
82
2020
129
16.810
Why?
Kidney Failure, Chronic
84
2019
485
14.430
Why?
Kidney
86
2020
1176
13.300
Why?
Calcium Channel Blockers
82
2018
226
10.800
Why?
Sympathectomy
22
2018
37
10.550
Why?
Adrenergic beta-Antagonists
54
2010
156
9.850
Why?
Renin-Angiotensin System
53
2018
129
9.780
Why?
Blood Pressure Monitoring, Ambulatory
48
2019
77
8.830
Why?
Angiotensin II Type 1 Receptor Blockers
45
2018
98
8.520
Why?
Hyperkalemia
27
2020
40
8.490
Why?
Humans
730
2020
74352
8.230
Why?
Hypoglycemic Agents
35
2020
342
7.810
Why?
Angiotensin Receptor Antagonists
39
2018
71
7.370
Why?
Glomerular Filtration Rate
85
2020
343
7.030
Why?
Diabetes Mellitus
49
2020
661
6.800
Why?
Proteinuria
41
2019
107
6.680
Why?
Drug Therapy, Combination
105
2018
943
6.610
Why?
Hypertension, Renal
18
2017
39
6.180
Why?
Hydrochlorothiazide
37
2018
84
6.160
Why?
Benzimidazoles
28
2018
128
6.130
Why?
Diabetic Angiopathies
26
2019
67
6.130
Why?
Practice Guidelines as Topic
44
2019
1018
5.700
Why?
Renal Artery
13
2018
64
5.460
Why?
Diabetes Complications
35
2018
208
5.150
Why?
Risk Factors
151
2020
4855
5.150
Why?
Tetrazoles
24
2018
54
5.060
Why?
Blood Pressure Determination
32
2020
90
4.940
Why?
Amlodipine
32
2018
42
4.930
Why?
Double-Blind Method
102
2020
1760
4.850
Why?
Diuretics
49
2019
145
4.850
Why?
Potassium
30
2020
295
4.780
Why?
Renal Dialysis
19
2019
357
4.610
Why?
Treatment Outcome
140
2020
7077
4.320
Why?
Sympathetic Nervous System
15
2018
110
4.130
Why?
Disease Progression
69
2020
1341
4.050
Why?
Creatinine
36
2019
328
4.030
Why?
Randomized Controlled Trials as Topic
49
2018
770
3.930
Why?
Oxadiazoles
14
2018
35
3.910
Why?
Aged
225
2020
16862
3.870
Why?
Middle Aged
250
2020
23594
3.840
Why?
Heart Failure
41
2020
860
3.760
Why?
Female
309
2020
40857
3.740
Why?
Male
305
2020
38562
3.730
Why?
Benzazepines
25
2018
90
3.430
Why?
Propanolamines
18
2010
38
3.400
Why?
Health Promotion
11
2009
155
3.380
Why?
Carbazoles
18
2010
50
3.360
Why?
Insulin Resistance
17
2010
359
3.320
Why?
Naphthyridines
6
2020
28
3.270
Why?
Electric Stimulation Therapy
8
2017
41
3.250
Why?
Denervation
9
2016
43
3.240
Why?
Societies, Medical
18
2019
468
3.170
Why?
Clinical Trials as Topic
44
2018
1124
3.130
Why?
Coronary Artery Disease
14
2018
314
3.130
Why?
Cardiovascular System
8
2020
69
3.070
Why?
Drug Resistance
21
2018
255
3.060
Why?
Diabetes Mellitus, Type 1
15
2018
498
3.030
Why?
Losartan
13
2018
45
2.880
Why?
Polymers
9
2020
213
2.840
Why?
Chlorthalidone
8
2018
31
2.830
Why?
Mass Screening
18
2017
567
2.670
Why?
United States
90
2019
5499
2.590
Why?
Imidazoles
13
2018
154
2.550
Why?
Drug Combinations
23
2018
218
2.500
Why?
Chronic Disease
42
2014
897
2.460
Why?
Catheter Ablation
8
2017
268
2.460
Why?
Uracil
14
2020
66
2.340
Why?
Benzopyrans
8
2013
22
2.320
Why?
Ethanolamines
8
2013
33
2.310
Why?
Thiazolidinediones
9
2013
90
2.270
Why?
Blood Glucose
33
2019
840
2.240
Why?
Fumarates
7
2015
24
2.200
Why?
Benzoates
12
2012
45
2.200
Why?
Amides
7
2015
55
2.180
Why?
Metoprolol
15
2013
29
2.170
Why?
Metformin
7
2016
90
2.160
Why?
Piperidines
14
2020
150
2.130
Why?
Goals
6
2018
43
2.130
Why?
Risk Reduction Behavior
5
2019
98
2.080
Why?
Hypertrophy, Left Ventricular
5
2016
68
2.080
Why?
Baroreflex
9
2017
16
2.050
Why?
Renin
13
2017
76
2.050
Why?
Spironolactone
8
2020
16
2.030
Why?
Endothelins
8
2015
33
2.020
Why?
African Americans
32
2018
998
2.020
Why?
Risk Assessment
45
2020
2053
2.000
Why?
Pressoreceptors
10
2017
19
1.950
Why?
Foundations
10
2011
24
1.950
Why?
Adult
118
2020
23811
1.890
Why?
Verapamil
14
2008
77
1.860
Why?
Cardiology
10
2019
100
1.860
Why?
Aldosterone
8
2016
61
1.820
Why?
Acute Coronary Syndrome
12
2020
39
1.770
Why?
Coronary Vasospasm
4
2018
12
1.720
Why?
Silicates
4
2016
7
1.720
Why?
Comorbidity
28
2020
833
1.700
Why?
Ramipril
10
2013
12
1.690
Why?
Glucosides
7
2020
18
1.660
Why?
Prospective Studies
48
2019
3527
1.660
Why?
Hypercholesterolemia
5
2017
237
1.630
Why?
Masked Hypertension
3
2018
4
1.620
Why?
Valine
7
2012
71
1.560
Why?
Prevalence
30
2018
1110
1.550
Why?
Renal Insufficiency
11
2018
107
1.530
Why?
Thiophenes
6
2015
40
1.530
Why?
Obesity
16
2016
860
1.490
Why?
Severity of Illness Index
28
2018
1620
1.470
Why?
Sodium-Glucose Transporter 2
5
2020
5
1.470
Why?
Perindopril
4
2015
8
1.430
Why?
Follow-Up Studies
46
2020
3605
1.430
Why?
Primary Prevention
7
2009
76
1.360
Why?
Myocardial Infarction
19
2020
341
1.360
Why?
Glucose
5
2019
584
1.360
Why?
Diabetic Cardiomyopathies
4
2018
7
1.360
Why?
Life Style
17
2014
173
1.350
Why?
Renal Circulation
14
2015
63
1.310
Why?
Lisinopril
10
2013
14
1.310
Why?
Vasodilator Agents
9
2010
170
1.310
Why?
Sodium
7
2019
321
1.300
Why?
Heart Rate
14
2017
483
1.270
Why?
Prognosis
38
2020
3377
1.260
Why?
Dipeptidyl-Peptidase IV Inhibitors
8
2020
13
1.260
Why?
Time Factors
34
2020
5209
1.250
Why?
Adrenergic beta-1 Receptor Antagonists
2
2015
8
1.250
Why?
Risk
17
2020
671
1.230
Why?
Atenolol
8
2010
41
1.230
Why?
Incidence
29
2018
1485
1.220
Why?
Sleep Apnea, Obstructive
3
2017
229
1.220
Why?
American Heart Association
7
2019
66
1.210
Why?
Acute Kidney Injury
5
2019
245
1.210
Why?
Acidosis, Lactic
2
2016
10
1.200
Why?
Hyperglycemia
7
2018
180
1.200
Why?
Hemodynamics
19
2013
649
1.190
Why?
Indoles
12
2009
301
1.190
Why?
Evidence-Based Medicine
14
2017
412
1.180
Why?
Dose-Response Relationship, Drug
32
2018
2040
1.170
Why?
Patient Education as Topic
9
2010
318
1.160
Why?
African Continental Ancestry Group
16
2015
539
1.150
Why?
Circadian Rhythm
8
2017
288
1.150
Why?
Physician's Role
4
2020
184
1.150
Why?
European Continental Ancestry Group
13
2018
1022
1.130
Why?
Hyperinsulinism
4
2007
50
1.130
Why?
Cardiovascular Agents
4
2017
49
1.110
Why?
Systole
20
2017
138
1.110
Why?
Diet, Sodium-Restricted
7
2017
16
1.100
Why?
Body Mass Index
12
2017
703
1.080
Why?
Sodium Chloride Symporter Inhibitors
7
2018
51
1.080
Why?
Biphenyl Compounds
8
2008
47
1.050
Why?
Primary Health Care
8
2020
246
1.020
Why?
Stroke
20
2020
685
1.010
Why?
Endothelium, Vascular
7
2010
434
0.990
Why?
Midodrine
2
2018
5
0.990
Why?
Research Design
14
2019
531
0.970
Why?
Delayed-Action Preparations
7
2010
147
0.960
Why?
Oleanolic Acid
6
2018
10
0.960
Why?
Capparis
1
2020
2
0.930
Why?
Hypotension
2
2018
64
0.930
Why?
Kidney Transplantation
6
2020
801
0.930
Why?
Early Diagnosis
11
2011
112
0.910
Why?
Patient Selection
11
2020
638
0.910
Why?
International Cooperation
3
2009
126
0.910
Why?
Drug Administration Schedule
17
2016
946
0.900
Why?
Animals
57
2017
25427
0.900
Why?
Cohort Studies
26
2017
2395
0.900
Why?
Polystyrenes
2
2016
8
0.880
Why?
Hyperuricemia
3
2018
26
0.880
Why?
Drug Substitution
2
2016
24
0.870
Why?
Carotid Sinus
4
2014
25
0.860
Why?
Vascular Diseases
4
2011
114
0.860
Why?
Age Factors
19
2018
1811
0.850
Why?
Hypokalemia
7
2020
30
0.850
Why?
Program Evaluation
7
2013
283
0.850
Why?
Dihydropyridines
5
2013
9
0.850
Why?
Symporters
1
2019
38
0.840
Why?
Panic Disorder
1
2018
24
0.840
Why?
Disease Management
12
2018
292
0.830
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
4
2012
431
0.820
Why?
Coronary Disease
5
2014
308
0.810
Why?
Indapamide
3
2013
4
0.800
Why?
Annual Reports as Topic
4
2011
5
0.800
Why?
Proportional Hazards Models
22
2019
809
0.790
Why?
Cross-Over Studies
8
2020
378
0.790
Why?
Diltiazem
10
2012
18
0.770
Why?
Leuprolide
1
2017
37
0.760
Why?
Health Behavior
1
2019
169
0.750
Why?
Thiazoles
4
2013
125
0.750
Why?
Aging
4
2017
654
0.750
Why?
Menstrual Cycle
1
2017
55
0.740
Why?
Periodicals as Topic
3
2014
156
0.740
Why?
Kidney Function Tests
8
2019
127
0.730
Why?
Benzhydryl Compounds
4
2020
38
0.730
Why?
Hypertension, Renovascular
2
2009
17
0.730
Why?
Gonadotropin-Releasing Hormone
1
2017
93
0.730
Why?
Hypolipidemic Agents
4
2011
118
0.730
Why?
Ventricular Dysfunction, Left
3
2017
282
0.730
Why?
Obesity, Abdominal
1
2016
5
0.720
Why?
Awareness
5
2010
80
0.710
Why?
Drugs, Generic
1
2016
13
0.710
Why?
Urinalysis
2
2007
41
0.690
Why?
Phenylpropionates
3
2010
9
0.690
Why?
Bisoprolol
1
2015
3
0.680
Why?
Diastole
11
2012
141
0.680
Why?
Doxazosin
1
2015
6
0.680
Why?
Adrenergic alpha-1 Receptor Antagonists
1
2015
8
0.680
Why?
Life Expectancy
1
2016
82
0.670
Why?
Arteries
2
2007
180
0.670
Why?
Uric Acid
2
2013
155
0.660
Why?
Parathyroid Hormone
4
2009
232
0.650
Why?
Cyclosporine
1
2016
247
0.650
Why?
Enalapril
5
2005
21
0.640
Why?
Early Termination of Clinical Trials
4
2016
18
0.630
Why?
Hypotension, Orthostatic
2
2014
7
0.630
Why?
Attitude to Health
2
2008
222
0.620
Why?
Sodium, Dietary
5
2014
11
0.620
Why?
Glomerular Mesangium
5
1994
23
0.610
Why?
Dyslipidemias
4
2011
113
0.610
Why?
Combined Modality Therapy
9
2018
1583
0.610
Why?
Gliclazide
1
2013
1
0.600
Why?
Cross-Sectional Studies
14
2012
1171
0.600
Why?
Insulin
6
2008
1122
0.600
Why?
Multicenter Studies as Topic
9
2018
135
0.600
Why?
Administration, Oral
9
2019
673
0.600
Why?
Patient Admission
1
2014
94
0.590
Why?
Vasodilation
3
2009
92
0.590
Why?
Predictive Value of Tests
16
2014
1561
0.590
Why?
Aged, 80 and over
31
2019
6047
0.590
Why?
Hospitalization
15
2020
646
0.590
Why?
Patient Compliance
8
2014
228
0.590
Why?
Heart Diseases
2
2008
299
0.580
Why?
Gout Suppressants
1
2013
32
0.580
Why?
Vascular Calcification
1
2014
33
0.580
Why?
Catheterization
1
2015
243
0.570
Why?
Prediabetic State
2
2016
34
0.570
Why?
Homeostasis
8
2015
376
0.570
Why?
Adolescent
26
2018
8375
0.570
Why?
Adrenal Gland Neoplasms
2
2010
99
0.560
Why?
Population Surveillance
5
2010
237
0.560
Why?
Gout
1
2013
72
0.560
Why?
Compliance
3
2007
23
0.560
Why?
Medication Adherence
6
2015
99
0.560
Why?
Body Weight
7
2014
469
0.560
Why?
Pyrimidines
3
2010
356
0.540
Why?
Uremia
1
2012
19
0.540
Why?
Health Priorities
2
2011
22
0.530
Why?
Nitric Oxide
3
2010
261
0.530
Why?
Analysis of Variance
10
2018
949
0.520
Why?
Reference Values
10
2018
668
0.520
Why?
Morbidity
7
2014
127
0.520
Why?
Cause of Death
9
2019
260
0.520
Why?
United Nations
1
2011
3
0.520
Why?
Aorta
1
2013
263
0.510
Why?
Nutrition Surveys
3
2011
78
0.510
Why?
Atherosclerosis
2
2012
209
0.510
Why?
Cardiotonic Agents
3
2008
82
0.510
Why?
Thiazides
4
2019
15
0.510
Why?
Contrast Media
6
1999
998
0.510
Why?
Delivery of Health Care
4
2014
253
0.510
Why?
Multivariate Analysis
14
2016
991
0.510
Why?
Inflammation
3
2011
730
0.510
Why?
Nephrology
6
2013
37
0.500
Why?
Health Education
2
2009
97
0.500
Why?
Exercise Test
1
2012
145
0.500
Why?
Leadership
2
2011
93
0.490
Why?
Health Knowledge, Attitudes, Practice
8
2012
468
0.490
Why?
Serum Albumin
2
2009
135
0.490
Why?
Fenofibrate
1
2011
28
0.480
Why?
Simvastatin
1
2011
133
0.480
Why?
Diuresis
3
2019
35
0.470
Why?
Angiotensin II
5
2004
89
0.470
Why?
Endothelium
2
2007
60
0.460
Why?
Calcium
4
2009
1201
0.460
Why?
Wounds, Nonpenetrating
1
2010
50
0.460
Why?
Europe
5
2019
284
0.460
Why?
Natriuresis
2
2007
30
0.460
Why?
Glucose Intolerance
2
2010
97
0.450
Why?
Consensus
4
2019
229
0.450
Why?
Anti-Obesity Agents
2
2016
14
0.450
Why?
Pregnancy Complications, Neoplastic
1
2010
29
0.450
Why?
Overweight
2
2016
102
0.450
Why?
Pheochromocytoma
1
2010
61
0.440
Why?
Diabetic Neuropathies
1
2009
29
0.440
Why?
Young Adult
14
2019
5159
0.430
Why?
Receptors, Angiotensin
3
2005
17
0.430
Why?
Forecasting
4
2016
295
0.420
Why?
Anemia
4
2020
121
0.420
Why?
Oxidative Stress
1
2011
369
0.410
Why?
Pilot Projects
7
2016
734
0.410
Why?
Blood Vessels
2
2005
99
0.400
Why?
Natriuretic Peptide, Brain
4
2020
57
0.400
Why?
Patient Care Planning
2
2012
73
0.400
Why?
Nifedipine
4
1998
33
0.390
Why?
Albumins
2
2006
114
0.390
Why?
Pulse
1
2007
22
0.390
Why?
Diatrizoate Meglumine
4
1999
24
0.380
Why?
Pre-Eclampsia
1
2010
202
0.380
Why?
Manipulation, Chiropractic
1
2007
2
0.380
Why?
Cervical Atlas
1
2007
6
0.380
Why?
Cystatin C
3
2018
28
0.380
Why?
C-Reactive Protein
3
2017
163
0.380
Why?
Metabolic Diseases
1
2008
50
0.370
Why?
Congresses as Topic
4
2014
103
0.370
Why?
Nitric Oxide Synthase
1
2007
124
0.360
Why?
Survival Rate
13
2019
1817
0.360
Why?
Continental Population Groups
5
2011
273
0.360
Why?
Fatty Acids, Nonesterified
1
2006
83
0.360
Why?
Diabetic Retinopathy
1
2007
59
0.360
Why?
Protein Kinase C
2
2007
295
0.360
Why?
Referral and Consultation
3
2011
281
0.360
Why?
Anti-Inflammatory Agents, Non-Steroidal
6
2008
231
0.360
Why?
Hispanic Americans
4
2010
354
0.350
Why?
Body Size
3
2013
87
0.350
Why?
Self Care
2
2007
135
0.350
Why?
Arginine Vasopressin
3
1997
46
0.350
Why?
Stroke Volume
3
2018
359
0.350
Why?
Dipeptides
4
2013
40
0.350
Why?
Chi-Square Distribution
6
2015
385
0.350
Why?
Cholesterol
3
2010
427
0.340
Why?
Advisory Committees
3
2011
83
0.340
Why?
Acrylates
1
2005
18
0.340
Why?
Kaplan-Meier Estimate
11
2013
856
0.330
Why?
Weight Loss
5
2013
201
0.330
Why?
Least-Squares Analysis
2
2015
52
0.330
Why?
Drug Evaluation
3
2008
152
0.330
Why?
Healthcare Disparities
1
2010
277
0.330
Why?
Vascular Resistance
4
2010
103
0.320
Why?
Clinical Trials, Phase III as Topic
2
2017
142
0.320
Why?
Survival Analysis
8
2019
1522
0.320
Why?
Education
2
2018
54
0.320
Why?
Heart Failure, Systolic
2
2016
7
0.320
Why?
Electrodes, Implanted
3
2016
162
0.320
Why?
Random Allocation
3
2020
361
0.310
Why?
Cytokines
1
2008
663
0.310
Why?
Regression Analysis
3
2016
615
0.310
Why?
Kidney Glomerulus
5
1999
116
0.310
Why?
Guidelines as Topic
3
2016
153
0.310
Why?
Dogs
9
2012
774
0.310
Why?
Peptide Fragments
3
2020
460
0.300
Why?
Cyclooxygenase Inhibitors
1
2004
41
0.300
Why?
Coronary Artery Bypass
1
2006
192
0.300
Why?
Glomerulosclerosis, Focal Segmental
4
2000
32
0.300
Why?
Japan
4
2017
286
0.300
Why?
Catheters
2
2015
34
0.290
Why?
Clonidine
4
1996
40
0.290
Why?
Enzyme Inhibitors
3
2018
661
0.290
Why?
Controlled Clinical Trials as Topic
2
2004
25
0.290
Why?
Maleimides
3
2009
30
0.290
Why?
Myocardial Revascularization
4
2017
33
0.280
Why?
Standard of Care
3
2017
31
0.280
Why?
Meta-Analysis as Topic
2
2013
101
0.280
Why?
Lactones
1
2002
32
0.280
Why?
Aortic Diseases
4
2010
104
0.270
Why?
Magnetic Resonance Imaging, Cine
2
2017
154
0.270
Why?
Aorta, Thoracic
4
2010
147
0.270
Why?
Physicians, Family
1
2002
38
0.270
Why?
Triglycerides
2
2009
310
0.270
Why?
Pharmacokinetics
2
2000
13
0.270
Why?
Sodium Chloride, Dietary
3
2006
8
0.260
Why?
Cost of Illness
3
2011
141
0.250
Why?
Adaptation, Physiological
2
1994
303
0.250
Why?
Exercise
4
2013
226
0.250
Why?
Quality-Adjusted Life Years
1
2002
98
0.250
Why?
Sex Factors
10
2018
1035
0.250
Why?
Diabetes Mellitus, Experimental
2
1993
186
0.240
Why?
Phenylbutyrates
1
2020
8
0.240
Why?
Education, Medical, Continuing
2
2013
91
0.240
Why?
Troponin I
2
2020
27
0.240
Why?
Epidermal Growth Factor
2
2012
120
0.240
Why?
Renal Artery Obstruction
2
2011
41
0.240
Why?
Algorithms
6
2010
1771
0.230
Why?
Retrospective Studies
13
2018
6340
0.230
Why?
Community Health Services
3
2010
62
0.230
Why?
Pharmacology, Clinical
1
2000
10
0.230
Why?
Single-Blind Method
4
2014
144
0.230
Why?
Thoracic Surgery
2
2010
27
0.230
Why?
Guideline Adherence
3
2008
213
0.220
Why?
Health Surveys
3
2009
236
0.220
Why?
Smoking
5
2013
543
0.220
Why?
Aortic Aneurysm, Thoracic
2
2010
58
0.220
Why?
Receptors, Dopamine D1
1
1999
37
0.210
Why?
Amine Oxidase (Copper-Containing)
1
2018
3
0.210
Why?
Amyotrophic Lateral Sclerosis
1
2020
162
0.210
Why?
Evaluation Studies as Topic
3
2010
318
0.210
Why?
History, 20th Century
2
2016
304
0.210
Why?
Feeding Behavior
3
2011
280
0.210
Why?
Myocardial Ischemia
2
2018
161
0.210
Why?
Vascular Surgical Procedures
2
2010
146
0.210
Why?
Prehypertension
2
2015
2
0.210
Why?
Health Care Costs
2
2011
203
0.210
Why?
Organic Chemicals
1
2018
35
0.210
Why?
Alcohol Drinking
3
2013
253
0.210
Why?
Hyperparathyroidism, Secondary
2
2009
70
0.210
Why?
Lipids
4
2011
376
0.200
Why?
Hypoglycemia
2
2017
100
0.200
Why?
Health Planning Guidelines
2
2008
29
0.200
Why?
Kidney Tubules
2
2007
100
0.200
Why?
Cell Adhesion Molecules
1
2018
155
0.190
Why?
Pharmaceutical Preparations
2
2000
59
0.190
Why?
Anxiety Disorders
1
2018
98
0.190
Why?
Intention to Treat Analysis
3
2014
59
0.190
Why?
Fertility Agents, Female
1
2017
4
0.190
Why?
Lithium
3
1983
52
0.190
Why?
Quality of Life
4
2018
1140
0.190
Why?
Osteoarthritis
2
2011
58
0.190
Why?
Phosphorus
2
2009
137
0.190
Why?
Logistic Models
6
2015
1085
0.190
Why?
Angina, Unstable
2
2015
8
0.190
Why?
Diet
3
2011
404
0.190
Why?
Direct Service Costs
1
1997
2
0.190
Why?
Nephritis, Interstitial
4
1994
48
0.190
Why?
Edema
2
2015
73
0.190
Why?
Population
1
1997
34
0.180
Why?
Glucose Tolerance Test
2
2008
232
0.180
Why?
Phenylurea Compounds
2
2014
102
0.180
Why?
Niacinamide
2
2014
115
0.180
Why?
Cholesterol, LDL
2
2017
323
0.180
Why?
Zirconium
1
2016
3
0.180
Why?
Sodium Chloride
1
1996
92
0.180
Why?
Caffeine
1
2017
78
0.180
Why?
Coronary Vessels
2
2015
172
0.180
Why?
Isradipine
1
1996
1
0.180
Why?
Reagent Strips
2
2007
8
0.180
Why?
Bupropion
1
2016
9
0.180
Why?
Dementia, Vascular
1
2016
4
0.180
Why?
Databases, Factual
3
2009
740
0.170
Why?
Nephritis
1
2016
21
0.170
Why?
Videoconferencing
2
2013
13
0.170
Why?
Asian Continental Ancestry Group
2
2015
323
0.170
Why?
Allopurinol
2
2013
80
0.170
Why?
Culture Media, Conditioned
1
2016
101
0.170
Why?
Decision Trees
3
2004
63
0.170
Why?
Nephrosclerosis
2
2009
9
0.170
Why?
Benchmarking
2
2008
48
0.170
Why?
Treatment Failure
3
2014
291
0.170
Why?
Postmenopause
1
2016
93
0.170
Why?
Cooperative Behavior
3
2011
165
0.170
Why?
Diagnostic Imaging
2
2010
419
0.170
Why?
Potassium, Dietary
2
2013
2
0.170
Why?
History, 21st Century
1
2016
163
0.170
Why?
Child
4
2014
6077
0.170
Why?
Diatrizoate
3
1990
16
0.160
Why?
Attitude of Health Personnel
4
2009
618
0.160
Why?
Genotype
5
2016
1780
0.160
Why?
Misoprostol
1
1995
9
0.160
Why?
Patient Safety
2
2014
201
0.160
Why?
Carotid Artery, Common
1
2014
28
0.160
Why?
Neoplasms
3
2014
2299
0.160
Why?
Calcium Channels, T-Type
2
2008
27
0.160
Why?
Ibuprofen
1
1995
28
0.160
Why?
Adipocytes
1
2016
149
0.160
Why?
Water-Electrolyte Imbalance
1
2014
13
0.160
Why?
Oxygen
2
1990
655
0.160
Why?
Autonomic Nervous System
1
2014
50
0.150
Why?
Residence Characteristics
4
2011
170
0.150
Why?
Central Nervous System Stimulants
1
2017
204
0.150
Why?
Naltrexone
1
2016
122
0.150
Why?
Fludrocortisone
1
2014
3
0.150
Why?
Stockings, Compression
1
2014
9
0.150
Why?
Linear Models
1
2015
416
0.150
Why?
Age Distribution
4
2008
200
0.150
Why?
Erythropoietin
2
2013
87
0.150
Why?
Receptors, Vascular Endothelial Growth Factor
1
2014
58
0.150
Why?
Medication Therapy Management
1
2013
12
0.150
Why?
Hyperaldosteronism
1
1993
17
0.150
Why?
Needs Assessment
1
2014
124
0.150
Why?
Accidental Falls
1
2014
52
0.150
Why?
Diabetes, Gestational
2
2011
34
0.150
Why?
Drug Therapy
1
2013
76
0.140
Why?
Erythropoiesis
1
2013
47
0.140
Why?
Mitogens
1
1993
67
0.140
Why?
Glucagon-Like Peptides
1
2013
7
0.140
Why?
Biguanides
1
2013
7
0.140
Why?
Adamantane
1
2013
8
0.140
Why?
Latin America
1
2013
11
0.140
Why?
Blood Volume
2
2008
50
0.140
Why?
Sleep
1
2017
379
0.140
Why?
Hydralazine
1
2012
8
0.140
Why?
Cost-Benefit Analysis
2
2007
364
0.140
Why?
Meglumine
1
2013
36
0.140
Why?
Reimbursement Mechanisms
1
2013
39
0.140
Why?
Blood Urea Nitrogen
1
2012
47
0.140
Why?
Program Development
2
2013
127
0.140
Why?
Atrial Fibrillation
1
2016
218
0.140
Why?
Clinical Laboratory Techniques
2
2011
80
0.140
Why?
Nitriles
1
2013
81
0.140
Why?
Pyrrolidines
1
2013
51
0.140
Why?
Specialization
1
2013
61
0.140
Why?
Community-Based Participatory Research
1
2013
36
0.140
Why?
Peptidyl-Dipeptidase A
2
2007
26
0.140
Why?
Sulfonylurea Compounds
1
2013
62
0.140
Why?
White Coat Hypertension
1
2012
1
0.140
Why?
Propensity Score
4
2016
113
0.140
Why?
Signal Transduction
4
2013
3151
0.130
Why?
Pyrazines
1
2013
82
0.130
Why?
Placebos
4
2014
217
0.130
Why?
Purines
1
2013
102
0.130
Why?
Hyperlipidemias
2
2011
131
0.130
Why?
Electric Power Supplies
1
2012
7
0.130
Why?
Secondary Prevention
3
2019
155
0.130
Why?
Equipment and Supplies
1
2012
29
0.130
Why?
Triazoles
1
2013
99
0.130
Why?
Family Practice
1
2013
92
0.130
Why?
Isoprostanes
1
2011
4
0.130
Why?
Sex Distribution
3
2008
165
0.130
Why?
Physical Fitness
1
2012
37
0.130
Why?
Organizational Objectives
2
2009
26
0.130
Why?
Malondialdehyde
1
2011
30
0.130
Why?
Receptors, Endothelin
1
2011
13
0.130
Why?
Intramolecular Oxidoreductases
1
2011
9
0.130
Why?
Adiponectin
1
2011
29
0.130
Why?
Odds Ratio
3
2009
666
0.130
Why?
Urban Health Services
1
2011
43
0.130
Why?
Lipocalins
1
2011
34
0.130
Why?
Cognition Disorders
1
2014
235
0.130
Why?
Case-Control Studies
5
2011
1694
0.130
Why?
Adrenergic alpha-Antagonists
4
2010
48
0.130
Why?
Digitalis Glycosides
2
2008
4
0.130
Why?
Continuous Positive Airway Pressure
1
2012
70
0.130
Why?
Rats
7
2014
4245
0.120
Why?
Vascular Endothelial Growth Factor A
1
2013
359
0.120
Why?
Norepinephrine
2
1994
172
0.120
Why?
Practice Management, Medical
1
2011
20
0.120
Why?
Nitric Oxide Donors
1
2011
14
0.120
Why?
Cell Line
2
2016
2544
0.120
Why?
Adenoma
1
1993
257
0.120
Why?
Peru
1
2011
16
0.120
Why?
Naproxen
1
2011
8
0.120
Why?
Argentina
1
2011
15
0.120
Why?
Health Policy
1
2013
154
0.120
Why?
Quinazolines
1
2013
209
0.120
Why?
World Health Organization
1
2011
92
0.120
Why?
Mexico
1
2011
58
0.120
Why?
Research Report
1
2011
32
0.120
Why?
Guanfacine
1
2010
2
0.120
Why?
Opioid-Related Disorders
2
1982
95
0.120
Why?
Greece
2
2007
13
0.120
Why?
Food Preferences
1
2010
19
0.120
Why?
Parasympathetic Nervous System
1
2010
33
0.120
Why?
Receptor, Angiotensin, Type 1
1
2010
19
0.120
Why?
Vagus Nerve
1
2010
42
0.120
Why?
Polycythemia
1
1990
8
0.120
Why?
General Practitioners
1
2010
7
0.120
Why?
Thrombosis
1
2012
229
0.120
Why?
Malnutrition
1
2010
21
0.120
Why?
Chicago
2
2013
1275
0.120
Why?
Telemedicine
1
2011
80
0.120
Why?
Dopamine
2
1994
284
0.120
Why?
Reproducibility of Results
2
2007
2485
0.120
Why?
Theophylline
1
1990
38
0.120
Why?
Mucoproteins
1
1990
16
0.120
Why?
Physicians, Primary Care
1
2011
89
0.120
Why?
Monitoring, Physiologic
4
2014
258
0.120
Why?
Arteriosclerosis
1
2010
164
0.120
Why?
Feedback, Physiological
1
2010
63
0.120
Why?
Hormones
1
2010
119
0.110
Why?
Probability
2
2008
345
0.110
Why?
Diet, Carbohydrate-Restricted
1
2009
3
0.110
Why?
Registries
2
2017
542
0.110
Why?
Heart Ventricles
2
2018
683
0.110
Why?
Glomerulonephritis, Membranous
1
1990
22
0.110
Why?
Anti-Inflammatory Agents
1
2013
318
0.110
Why?
Diet, Reducing
1
2009
21
0.110
Why?
Cytochrome P-450 CYP3A
1
2009
40
0.110
Why?
Biomedical Research
2
2013
317
0.110
Why?
Mice
3
2013
10356
0.110
Why?
Interdisciplinary Communication
1
2011
130
0.110
Why?
Brain Stem
1
2010
153
0.110
Why?
Labetalol
1
2009
5
0.110
Why?
Sodium-Glucose Transport Proteins
1
2009
1
0.110
Why?
Stress, Psychological
1
2013
283
0.110
Why?
Hemoglobinometry
1
2009
8
0.110
Why?
Pyridoxamine
1
2009
2
0.110
Why?
Drug Industry
1
2009
39
0.110
Why?
Longitudinal Studies
4
2013
858
0.110
Why?
G-Protein-Coupled Receptor Kinase 4
1
2009
2
0.110
Why?
Pregnancy
3
2011
2509
0.110
Why?
Peroxisome Proliferator-Activated Receptors
1
2009
7
0.110
Why?
Echocardiography, Doppler
1
2010
184
0.110
Why?
Smoking Cessation
1
2011
159
0.110
Why?
Models, Biological
3
2009
1720
0.110
Why?
Confidence Intervals
3
2016
234
0.110
Why?
Antineoplastic Agents
2
2012
2210
0.110
Why?
Social Environment
1
2010
186
0.110
Why?
Marriage
1
2009
33
0.110
Why?
Cardiac Output
1
2009
143
0.110
Why?
Superoxides
1
2009
78
0.100
Why?
Internal Medicine
1
2013
321
0.100
Why?
Chronotherapy
1
2008
4
0.100
Why?
Half-Life
1
2008
107
0.100
Why?
Drug Dosage Calculations
1
2008
15
0.100
Why?
Motor Activity
1
2011
327
0.100
Why?
Receptors, Dopamine
1
1988
44
0.100
Why?
Placebo Effect
2
2019
28
0.100
Why?
Dopamine Agents
1
1988
31
0.100
Why?
Drug Tolerance
1
2008
67
0.100
Why?
National Health Programs
1
2007
19
0.100
Why?
Infant, Low Birth Weight
1
2007
50
0.100
Why?
Dietary Supplements
1
2009
128
0.100
Why?
Cell Division
4
1994
753
0.100
Why?
Treatment Refusal
1
2008
57
0.100
Why?
Polypharmacy
1
2007
11
0.100
Why?
Nephrectomy
4
2000
271
0.090
Why?
Research
2
2008
247
0.090
Why?
Age of Onset
1
2008
295
0.090
Why?
Carbohydrate Metabolism
1
2007
32
0.090
Why?
Endpoint Determination
2
2013
57
0.090
Why?
Propranolol
1
1986
44
0.090
Why?
Glyburide
1
2006
30
0.090
Why?
Forearm
1
1986
33
0.090
Why?
Sensitivity and Specificity
2
2003
2039
0.090
Why?
Chromans
1
2006
29
0.090
Why?
Statistics as Topic
3
2006
231
0.090
Why?
Evidence-Based Practice
2
2020
44
0.090
Why?
Mortality
2
2004
128
0.090
Why?
Pain
3
2007
324
0.090
Why?
Posture
1
1986
107
0.090
Why?
Drug Utilization
2
2003
66
0.090
Why?
Recurrence
3
2018
1106
0.090
Why?
Aspirin
2
2004
120
0.090
Why?
Endothelin-1
1
2006
42
0.090
Why?
Alabama
3
2012
17
0.090
Why?
PPAR gamma
1
2006
67
0.090
Why?
Drug Eruptions
2
1991
37
0.090
Why?
Heptanoic Acids
1
2006
106
0.080
Why?
Cerebrovascular Circulation
1
2007
190
0.080
Why?
Blood Coagulation
1
2006
77
0.080
Why?
Substance Withdrawal Syndrome
2
1982
47
0.080
Why?
Myocardial Contraction
1
2006
242
0.080
Why?
Pediatrics
1
2010
330
0.080
Why?
Androstenes
1
2005
31
0.080
Why?
Eating
1
2006
156
0.080
Why?
Osteoporosis, Postmenopausal
1
2005
34
0.080
Why?
Cultural Characteristics
1
2005
30
0.080
Why?
Women's Health Services
1
2005
15
0.080
Why?
Medical Audit
1
2005
38
0.080
Why?
Professional-Patient Relations
1
2005
52
0.080
Why?
Diagnosis, Differential
3
2000
1554
0.080
Why?
Transforming Growth Factor beta
1
2007
268
0.080
Why?
Drugs, Investigational
1
2005
33
0.080
Why?
Pyrroles
1
2006
209
0.080
Why?
Diclofenac
1
2004
5
0.080
Why?
Physicians
1
2011
537
0.080
Why?
Radiography
2
2014
848
0.080
Why?
Estradiol
1
2005
255
0.080
Why?
Athetosis
1
1983
6
0.080
Why?
Ubiquitin-Protein Ligases
1
2005
153
0.080
Why?
Cyclooxygenase 2 Inhibitors
1
2004
35
0.080
Why?
Polymorphism, Single Nucleotide
3
2009
2178
0.080
Why?
Prostaglandin-Endoperoxide Synthases
1
2004
36
0.080
Why?
Polymorphism, Genetic
1
2009
818
0.080
Why?
Epidemiologic Studies
1
2003
18
0.080
Why?
Chorea
1
1983
15
0.070
Why?
Drug Prescriptions
1
2005
111
0.070
Why?
Clinical Competence
2
2011
643
0.070
Why?
Ultrasonography, Interventional
2
2015
105
0.070
Why?
Vitamin D
1
2006
237
0.070
Why?
Cyclooxygenase 2
1
2004
94
0.070
Why?
RNA, Messenger
2
2009
1942
0.070
Why?
Disopyramide
1
1983
1
0.070
Why?
Chromatography, High Pressure Liquid
1
2004
317
0.070
Why?
Peritoneal Dialysis
1
2003
33
0.070
Why?
Rats, Sprague-Dawley
4
2001
1334
0.070
Why?
Behavior Therapy
1
1983
54
0.070
Why?
Cholestasis
1
1983
48
0.070
Why?
Isoenzymes
1
2004
273
0.070
Why?
Pyrazoles
1
2004
144
0.070
Why?
Energy Intake
1
2002
87
0.070
Why?
Carcinoma, Small Cell
1
1983
141
0.070
Why?
Apoprotein(a)
1
2002
3
0.070
Why?
Orphenadrine
1
1982
2
0.070
Why?
Models, Educational
2
2013
50
0.070
Why?
Apolipoproteins
1
2002
55
0.070
Why?
Analgesics
1
1983
103
0.070
Why?
Pain, Intractable
1
1982
19
0.070
Why?
Models, Econometric
1
2002
16
0.070
Why?
Aquaporins
1
2002
13
0.070
Why?
Psychophysiologic Disorders
1
1981
7
0.070
Why?
Lipoprotein(a)
1
2002
35
0.060
Why?
Vertigo
1
1981
11
0.060
Why?
Pain Management
1
1983
97
0.060
Why?
Vasopressins
1
2002
50
0.060
Why?
Headache
1
1982
66
0.060
Why?
Mibefradil
1
2001
4
0.060
Why?
Gastrointestinal Tract
1
2004
171
0.060
Why?
Sulfonamides
1
2004
281
0.060
Why?
Markov Chains
1
2002
116
0.060
Why?
Polyuria
1
1981
8
0.060
Why?
Calcium Channels, L-Type
1
2001
44
0.060
Why?
Cholesterol, HDL
1
2002
203
0.060
Why?
Pyridines
1
1983
285
0.060
Why?
Disease-Free Survival
2
2014
1172
0.060
Why?
Haplotypes
3
2009
622
0.060
Why?
Culture
1
2000
55
0.060
Why?
Growth Differentiation Factor 15
1
2020
8
0.060
Why?
Galectin 3
1
2020
12
0.060
Why?
Free Radicals
2
1990
78
0.060
Why?
Echocardiography
2
2018
759
0.060
Why?
Causality
2
2010
68
0.060
Why?
Kidney Tubules, Proximal
1
2020
66
0.060
Why?
Matched-Pair Analysis
2
2010
44
0.060
Why?
Disease Models, Animal
3
1999
2113
0.060
Why?
Felodipine
1
1999
5
0.050
Why?
Microvessels
1
2019
68
0.050
Why?
Genetic Predisposition to Disease
1
2008
2044
0.050
Why?
Gastrointestinal Diseases
1
2020
139
0.050
Why?
Statistics, Nonparametric
2
2010
320
0.050
Why?
Pulmonary Edema
1
1998
50
0.050
Why?
Indians, North American
1
1998
56
0.050
Why?
Child, Preschool
1
2006
3572
0.050
Why?
Peripheral Vascular Diseases
1
1998
61
0.050
Why?
Canada
2
2010
184
0.050
Why?
Drug Synergism
1
1998
322
0.050
Why?
Cells, Cultured
3
1993
2853
0.050
Why?
Terminology as Topic
2
2013
197
0.050
Why?
Hormone Antagonists
1
1997
21
0.050
Why?
Genetic Testing
2
2011
446
0.050
Why?
Membrane Proteins
1
2004
1127
0.050
Why?
Syndrome
1
1997
422
0.040
Why?
Weight Reduction Programs
1
2016
10
0.040
Why?
Carcinoma, Squamous Cell
1
1983
998
0.040
Why?
Risk Management
1
2016
45
0.040
Why?
Confidentiality
1
2016
72
0.040
Why?
Arteriovenous Shunt, Surgical
1
2016
69
0.040
Why?
United States Food and Drug Administration
1
2016
110
0.040
Why?
Plaque, Atherosclerotic
1
2015
35
0.040
Why?
Sample Size
1
2016
117
0.040
Why?
Equipment Design
1
2016
403
0.040
Why?
Catheterization, Central Venous
1
2016
131
0.040
Why?
Neoplasm Metastasis
2
2014
974
0.040
Why?
Adenocarcinoma
1
1983
1182
0.040
Why?
Maximum Tolerated Dose
1
2015
264
0.040
Why?
Prostaglandins
1
1994
55
0.040
Why?
Atrial Natriuretic Factor
1
1994
38
0.040
Why?
Macaca fascicularis
1
2014
124
0.040
Why?
Mental Status Schedule
1
2014
25
0.040
Why?
Mitosis
1
1994
140
0.040
Why?
Erythrocyte Count
1
2013
20
0.040
Why?
NF-E2-Related Factor 2
1
2013
30
0.040
Why?
Asia
1
2013
81
0.040
Why?
Urine
1
2014
103
0.040
Why?
Endocrinology
1
1993
26
0.040
Why?
Fibrosis
1
1994
164
0.040
Why?
Adrenalectomy
1
1993
64
0.040
Why?
Clinical Trials Data Monitoring Committees
1
2013
6
0.040
Why?
Furosemide
1
1993
37
0.040
Why?
Indazoles
1
2013
42
0.040
Why?
Internet
1
2016
293
0.030
Why?
Carotid Arteries
1
2014
126
0.030
Why?
Endomyocardial Fibrosis
1
2012
6
0.030
Why?
Platelet Aggregation Inhibitors
1
2013
93
0.030
Why?
Physical Examination
1
2014
144
0.030
Why?
Urban Health
1
2013
54
0.030
Why?
Capillaries
1
1993
88
0.030
Why?
Urinary Tract Infections
1
2013
69
0.030
Why?
Prostheses and Implants
1
2014
138
0.030
Why?
Pulmonary Medicine
1
2013
43
0.030
Why?
Growth Substances
1
1992
88
0.030
Why?
Oligonucleotides, Antisense
1
1992
70
0.030
Why?
Ventricular Remodeling
1
2012
73
0.030
Why?
Self-Assessment
1
2011
46
0.030
Why?
Microcirculation
1
1992
104
0.030
Why?
Glycosuria
1
2011
6
0.030
Why?
Lung Neoplasms
1
1983
1884
0.030
Why?
Tobramycin
1
1991
18
0.030
Why?
Ketone Bodies
1
2011
17
0.030
Why?
Psychotropic Drugs
2
1983
70
0.030
Why?
Tomography, X-Ray Computed
2
2010
2424
0.030
Why?
Immunologic Techniques
1
1991
30
0.030
Why?
Biological Availability
1
2011
100
0.030
Why?
Interviews as Topic
1
2013
316
0.030
Why?
Ethnic Groups
1
2014
422
0.030
Why?
Fluorouracil
1
2013
568
0.030
Why?
Arrhythmias, Cardiac
1
2012
169
0.030
Why?
Educational Measurement
1
2013
199
0.030
Why?
Metabolic Clearance Rate
1
1990
128
0.030
Why?
Quality of Health Care
2
2006
340
0.030
Why?
Depression, Chemical
1
1990
32
0.030
Why?
Drug Monitoring
1
2011
89
0.030
Why?
Patient Preference
1
2011
89
0.030
Why?
Neurology
1
2011
55
0.030
Why?
Hydrocortisone
1
2012
299
0.030
Why?
Hematocrit
1
1990
78
0.030
Why?
Aortography
1
2010
59
0.030
Why?
Iothalamic Acid
1
1990
12
0.030
Why?
Uromodulin
1
1990
16
0.030
Why?
Geriatrics
1
2011
55
0.030
Why?
Infusions, Intra-Arterial
1
1990
33
0.030
Why?
Phenotype
1
2016
2084
0.030
Why?
Sympatholytics
1
1989
7
0.030
Why?
Teaching
1
2011
140
0.030
Why?
Anticoagulants
1
2013
340
0.030
Why?
Socioeconomic Factors
2
2002
516
0.030
Why?
Radio Waves
2
2000
18
0.030
Why?
Autoantibodies
1
2011
237
0.030
Why?
Genetic Markers
1
2011
490
0.030
Why?
Receptor, Endothelin A
1
2009
20
0.030
Why?
Glomerulonephritis
1
1990
72
0.030
Why?
Postoperative Complications
2
2010
2107
0.030
Why?
Patient Participation
1
2011
182
0.030
Why?
Telemetry
2
2000
35
0.030
Why?
Asian Americans
1
2010
105
0.030
Why?
Cyclic AMP
1
1990
278
0.030
Why?
Hot Temperature
1
1990
188
0.030
Why?
Xanthine Oxidase
1
2009
25
0.030
Why?
Curriculum
1
2013
394
0.030
Why?
Up-Regulation
1
2011
664
0.030
Why?
National Heart, Lung, and Blood Institute (U.S.)
1
2008
9
0.030
Why?
Electrocardiography
1
2011
510
0.030
Why?
Superoxide Dismutase
1
1990
180
0.030
Why?
Cerebral Hemorrhage
1
2011
265
0.030
Why?
Fenoldopam
1
1988
14
0.030
Why?
Finland
1
2008
28
0.020
Why?
Health Services Needs and Demand
1
2009
91
0.020
Why?
Receptors, Purinergic
1
1987
6
0.020
Why?
Magnetic Resonance Angiography
1
2010
215
0.020
Why?
Bipolar Disorder
2
1981
345
0.020
Why?
Bronchial Spasm
1
2007
16
0.020
Why?
Neuroblastoma
1
1992
436
0.020
Why?
Heart Block
1
2007
42
0.020
Why?
Bradycardia
1
2007
34
0.020
Why?
Islets of Langerhans
1
2011
516
0.020
Why?
Health Status Indicators
1
2008
104
0.020
Why?
Calcifediol
1
2006
21
0.020
Why?
Sexual Dysfunction, Physiological
1
2007
50
0.020
Why?
Antibodies, Monoclonal
1
1994
1409
0.020
Why?
Ventricular Function, Left
1
2011
498
0.020
Why?
Sex Characteristics
1
2009
287
0.020
Why?
Hemoglobins
1
2007
162
0.020
Why?
Shear Strength
1
2006
13
0.020
Why?
Fatigue
1
2007
159
0.020
Why?
Nervous System Diseases
1
2007
142
0.020
Why?
von Willebrand Factor
1
2006
35
0.020
Why?
Alleles
1
2009
1071
0.020
Why?
Endosomal Sorting Complexes Required for Transport
1
2005
17
0.020
Why?
Calcitriol
1
2006
179
0.020
Why?
Egtazic Acid
1
1985
36
0.020
Why?
Ischemic Attack, Transient
1
2006
166
0.020
Why?
Adenosine
1
1987
197
0.020
Why?
Vasoconstriction
1
1985
100
0.020
Why?
Safety
1
2005
163
0.020
Why?
Lithium Carbonate
1
1983
7
0.020
Why?
Anti-Bacterial Agents
1
1989
716
0.020
Why?
Carbamazepine
1
1983
11
0.020
Why?
Mass Chest X-Ray
1
1983
8
0.020
Why?
Gallium Radioisotopes
1
1983
30
0.020
Why?
Blood Pressure Monitors
1
2003
12
0.020
Why?
Linkage Disequilibrium
1
2005
473
0.020
Why?
Adrenergic alpha-Agonists
1
2003
38
0.020
Why?
National Institutes of Health (U.S.)
1
2003
93
0.020
Why?
5-Hydroxytryptophan
1
1982
6
0.020
Why?
Levorphanol
1
1982
3
0.020
Why?
Hydroxyindoleacetic Acid
1
1982
24
0.020
Why?
Cognition
1
2007
447
0.020
Why?
Ion Channels
1
1985
254
0.020
Why?
Diagnostic Tests, Routine
1
2003
55
0.020
Why?
Pedigree
1
2005
992
0.020
Why?
DNA
1
2009
1270
0.020
Why?
Depressive Disorder
1
1983
212
0.020
Why?
Prejudice
1
2002
53
0.020
Why?
Cornell Medical Index
1
1981
1
0.020
Why?
Receptors, Opioid
1
1982
26
0.020
Why?
Models, Statistical
1
2006
558
0.020
Why?
Anticonvulsants
1
1983
110
0.020
Why?
Infant, Newborn
1
2007
2244
0.020
Why?
Chromosome Mapping
1
2005
1086
0.020
Why?
Personality Inventory
1
1981
94
0.020
Why?
Serotonin
1
1982
226
0.020
Why?
Muscle Contraction
1
1982
304
0.010
Why?
Self Administration
1
2000
76
0.010
Why?
Antibodies, Antinuclear
1
1980
87
0.010
Why?
Analgesics, Opioid
1
1983
287
0.010
Why?
Hypertrophy
1
1999
66
0.010
Why?
Drinking
1
1999
39
0.010
Why?
Health Services Accessibility
1
2002
345
0.010
Why?
Cluster Analysis
1
2000
358
0.010
Why?
Brain
1
2007
1952
0.010
Why?
Psoriasis
1
1980
202
0.010
Why?
Hybrid Cells
1
1992
89
0.010
Why?
Peritonitis
1
1991
33
0.010
Why?
Peritoneal Dialysis, Continuous Ambulatory
1
1991
19
0.010
Why?
Injections, Intraperitoneal
1
1991
110
0.010
Why?
Injections, Intravenous
1
1991
260
0.010
Why?
Protein Biosynthesis
1
1992
363
0.010
Why?
Steroids
1
1990
154
0.010
Why?
Polymerase Chain Reaction
1
1992
987
0.010
Why?
Dipyridamole
1
1987
13
0.010
Why?
Staphylococcal Infections
1
1991
276
0.010
Why?
Regional Blood Flow
1
1987
196
0.010
Why?
Base Sequence
1
1992
2384
0.010
Why?
Transcription, Genetic
1
1992
1126
0.010
Why?
Molecular Sequence Data
1
1992
3177
0.010
Why?
Body Fluids
1
1982
42
0.000
Why?
Haplorhini
1
1982
113
0.000
Why?
Chromatography, Liquid
1
1982
105
0.000
Why?
Bakris's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_